Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

4.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.6K
Metastasis02:30

Metastasis

6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting histone deacetylation, cell cycle regulators and heat shock proteins as novel therapeutic strategies for penile cancers.

NPJ precision oncology·2026
Same author

[Treatment options in rare urological tumors: potential of molecular tumor boards].

Urologie (Heidelberg, Germany)·2025
Same author

[The WHO Classification of Renal Cell Tumours: Implications for Personalised Treatment Decisions and Accurate Detection of Hereditary Renal Cell Carcinomas].

Aktuelle Urologie·2025
Same author

[Penile carcinoma: the importance of histological classification and new treatment strategies].

Aktuelle Urologie·2025
Same author

Treatment Strategies in Oligo-Metastatic Prostate Cancer: A Nationwide Survey.

Urologia internationalis·2025
Same author

Machine Learning Accurately Predicts Muscle Invasion of Bladder Cancer Based on Three miRNAs.

Journal of cellular and molecular medicine·2025

Related Experiment Video

Updated: Jan 2, 2026

Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.9K

Extracellular vesicles in urological malignancies: an update.

Johannes Linxweiler1, Kerstin Junker2

  • 1Department of Urology and Pediatric Urology, Saarland University, Homburg/Saar, Germany.

Nature Reviews. Urology
|December 13, 2019
PubMed
Summary

Extracellular vesicles (EVs) show promise as biomarkers for genitourinary cancers. Standardizing EV isolation and analysis is crucial for developing reliable diagnostic and therapeutic applications.

More Related Videos

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.6K
Extraction of Extracellular Vesicles from Whole Tissue
09:03

Extraction of Extracellular Vesicles from Whole Tissue

Published on: February 7, 2019

15.9K

Related Experiment Videos

Last Updated: Jan 2, 2026

Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.9K
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.6K
Extraction of Extracellular Vesicles from Whole Tissue
09:03

Extraction of Extracellular Vesicles from Whole Tissue

Published on: February 7, 2019

15.9K

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Extracellular vesicles (EVs) play a key role in genitourinary cancer progression, metastasis, and drug resistance.
  • EVs contain diverse biomolecules (DNA, RNA, proteins, lipids) with potential as diagnostic, prognostic, and predictive biomarkers.

Purpose of the Study:

  • To review the potential of EVs as biomarkers in bladder, kidney, and prostate cancer.
  • To highlight challenges and future directions for EV-based biomarker development and therapeutic applications.

Main Methods:

  • Review of existing literature on EVs in genitourinary cancers.
  • Analysis of biomolecules within EVs from blood and urine samples.
  • Exploration of emerging technologies for EV analysis and separation.

Main Results:

  • Promising EV-derived biomarker candidates have been identified, but results are heterogeneous.
  • Lack of standardized methods for EV isolation, characterization, and analysis hinders result comparison.
  • Validation in independent cohorts and prospective trials is rarely performed.

Conclusions:

  • Standardization of EV research methods is essential for reliable biomarker development.
  • Emerging technologies may improve cancer-associated EV detection and separation.
  • EVs hold potential as therapeutic drug delivery vehicles for cancer treatment.